Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression.
about
Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistanceXpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adultsXpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adultsXpert MTB/RIF test for detection of pulmonary tuberculosis and rifampicin resistanceAccuracy of the Bronchoalveolar Lavage Enzyme-Linked Immunospot Assay for the Diagnosis of Pulmonary Tuberculosis: A Meta-analysisDiagnostics for pulmonary tuberculosisEuropean union standards for tuberculosis careAdvances in the diagnosis of pulmonary tuberculosis in HIV-infected and HIV-uninfected childrenTuberculosis: From an incurable scourge to a curable disease - journey over a millenniumPoint-of-care diagnosis of tuberculosis: past, present and futureDiagnostic value of nucleic acid amplification tests on bronchoalveolar lavage fluid for smear-negative pulmonary tuberculosis: a meta-analysisThe rotary zone thermal cycler: a low-power system enabling automated rapid PCRClinical research and development of tuberculosis diagnostics: moving from silos to synergyComparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective studyResearch questions and priorities for tuberculosis: a survey of published systematic reviews and meta-analysesCurrent developments and future perspectives for TB diagnostics.Evidence-based tuberculosis diagnosis.Evaluation of the hyplex TBC PCR test for detection of Mycobacterium tuberculosis complex in clinical samplesSputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis.Diagnostic accuracy of nucleic acid amplification tests (NAATs) in urine for genitourinary tuberculosis: a systematic review and meta-analysis.Use of amplified Mycobacterium tuberculosis direct test in respiratory samples from HIV-infected patients in Brazil.Comparison of laboratory testing methods for the diagnosis of tuberculous pleurisy in China.The changing epidemiology of tuberculosis in a Spanish tertiary hospital (1995-2013)Rapid point-of-care detection of the tuberculosis pathogen using a BlaC-specific fluorogenic probeDetection of a substantial rate of multidrug-resistant tuberculosis in an HIV-infected population in South Africa by active monitoring of sputum samples.Interferon-gamma assay in combination with tuberculin skin test are insufficient for the diagnosis of culture-negative pulmonary tuberculosis.A toolbox for tuberculosis diagnosis: an Indian multicentric study (2006-2008): microbiological results.Tuberculosis as part of the natural history of HIV infection in developing countriesRole of the clinical mycobacteriology laboratory in diagnosis and management of tuberculosis in low-prevalence settingsEvaluation of the Cobas TaqMan MTB test for direct detection of Mycobacterium tuberculosis complex in respiratory specimens.Rapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementationEvaluation and comparison of molecular and conventional diagnostic tests for detecting tuberculosis in Korea, 2013.High-throughput sequencing enhanced phage display identifies peptides that bind mycobacteriaLaboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunitiesRapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system.Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysisMycobacteria in terrestrial small mammals on cattle farms in TanzaniaIs scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosisBridging implementation, knowledge, and ambition gaps to eliminate tuberculosis in the United States and globallyImmunodiagnosis of tuberculosis: a dynamic view of biomarker discovery
P2860
Q22241307-0154F498-E4CE-4032-A86F-DDDCAE41E752Q24200879-25E1F42F-DD0C-4B86-9EC2-0D720BDE8E54Q24201466-D421214D-20B2-4705-AEFD-DE543F85CF6CQ24203927-30532B12-D889-4177-8E1F-974ACD9DDFDFQ26750756-EE6574EF-F8A0-4A3A-A42A-471C02B3DFAAQ26752633-3031BAE2-E09D-465D-89C8-07C75AAA2365Q26823223-CD2BEEF5-98B8-49AD-A00A-7FECFA0D4568Q26852073-73AA5681-2DA1-498F-94C5-3B53869F7C69Q26865560-0A479DA6-7F87-44DA-972D-057801DCE883Q27004667-6BB9863A-FB0D-4BDC-A52D-F1D37C9FBA7AQ27023121-865B265D-7B3B-43DE-A0D5-29B62E729664Q27314647-18298E0E-6004-40B2-A9BF-75AE98CC74C0Q28383710-C1B5288D-BAAC-494A-B4EA-77CA77324B3CQ28479276-C785480F-D202-4139-A25E-3F1D48267B1BQ28481610-2336CEF2-EE3D-42FF-A62B-6DACBF256D08Q30410962-455A7A86-F59D-4CF8-9E4A-6A0AD4D94915Q33354570-771D9334-A798-4ED1-A2F9-4FDE83A104FDQ33548100-289D62F8-1031-4758-B1BA-3B643EDDBF6BQ33590272-A96979D6-9C2B-407A-BB7A-02E90D57E879Q33767720-472C993D-C2CA-4BDF-BD40-81F3B38D1434Q33852416-08CCFCB0-3DD8-418F-97DB-975F4878228EQ33866751-B3A53086-10DE-49AD-8049-8C1B6B08063BQ33879669-9B1191F5-5E61-4202-9CAB-CDE6398D2A03Q34060501-5CC301C3-68F5-498B-9F4F-8D8C74822586Q34162789-809646E9-7764-4B4B-AD01-D0C4AB8CA741Q34184039-A1EA1120-1574-42DB-8194-B8C0EEB6FE72Q34399361-49316F5A-5DF5-4253-A234-7A028691CB65Q34547644-355AD15C-C4A7-4023-9F70-08CCF3D90412Q34741471-D7A5F0CF-C9FD-4FF3-B3EA-A31F2CF6056CQ34741490-41D90D4A-2D48-4C78-9E97-AF73F0E0BFEAQ34976354-E1C34DA7-387F-4DD2-BBE2-A4C52E037C97Q34994255-3DDA4B9B-9CB5-430F-8C8B-C90328591365Q35050264-3FCDDB21-23B4-47A5-A285-28EA26763FF1Q35066020-5A33DFE6-53A7-46EC-B064-C6C3D33448D3Q35067040-A153DEDD-01E4-44D2-8330-488C3DBCE293Q35075418-4CA604D9-2D1C-450E-A8B1-8008D04EF834Q35113854-86185B48-7C8D-4516-98E1-5DC95DD1A662Q35129505-099AC5FF-A072-460B-9DE8-0FA053240221Q35193579-443F48BC-1E3C-426D-BE7D-BD439E35EF9EQ35361654-5E0C7D3E-570D-4A71-A20A-2D2C1ECD9432
P2860
Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Commercial nucleic-acid amplif ...... -analysis and meta-regression.
@ast
Commercial nucleic-acid amplif ...... -analysis and meta-regression.
@en
Commercial nucleic-acid amplif ...... -analysis and meta-regression.
@nl
type
label
Commercial nucleic-acid amplif ...... -analysis and meta-regression.
@ast
Commercial nucleic-acid amplif ...... -analysis and meta-regression.
@en
Commercial nucleic-acid amplif ...... -analysis and meta-regression.
@nl
prefLabel
Commercial nucleic-acid amplif ...... -analysis and meta-regression.
@ast
Commercial nucleic-acid amplif ...... -analysis and meta-regression.
@en
Commercial nucleic-acid amplif ...... -analysis and meta-regression.
@nl
P2093
P2860
P921
P1433
P1476
Commercial nucleic-acid amplif ...... -analysis and meta-regression.
@en
P2093
Daphne I Ling
Laura L Flores
Lee W Riley
P2860
P356
10.1371/JOURNAL.PONE.0001536
P407
P50
P577
2008-02-06T00:00:00Z